- Home
- AIO vs INMD Comparison
AIO vs INMD Comparison
Compare AIO & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIO
- INMD
- Stock Information
- Founded
- AIO 2019
- INMD 2008
- Country
- AIO United States
- INMD Israel
- Employees
- AIO N/A
- INMD N/A
- Industry
- AIO Finance/Investors Services
- INMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- AIO Finance
- INMD Health Care
- Exchange
- AIO Nasdaq
- INMD Nasdaq
- Market Cap
- AIO 826.9M
- INMD 887.6M
- IPO Year
- AIO N/A
- INMD 2019
- Fundamental
- Price
- AIO $23.60
- INMD $14.66
- Analyst Decision
- AIO
- INMD Hold
- Analyst Count
- AIO 0
- INMD 6
- Target Price
- AIO N/A
- INMD $17.56
- AVG Volume (30 Days)
- AIO 141.5K
- INMD 1.0M
- Earning Date
- AIO 01-01-0001
- INMD 04-28-2025
- Dividend Yield
- AIO 9.05%
- INMD N/A
- EPS Growth
- AIO N/A
- INMD 8.69
- EPS
- AIO N/A
- INMD 2.29
- Revenue
- AIO N/A
- INMD $392,408,000.00
- Revenue This Year
- AIO N/A
- INMD $0.40
- Revenue Next Year
- AIO N/A
- INMD $5.92
- P/E Ratio
- AIO N/A
- INMD $6.39
- Revenue Growth
- AIO N/A
- INMD N/A
- 52 Week Low
- AIO $15.09
- INMD $13.68
- 52 Week High
- AIO $20.25
- INMD $19.85
- Technical
- Relative Strength Index (RSI)
- AIO 73.35
- INMD 47.89
- Support Level
- AIO $22.11
- INMD $13.99
- Resistance Level
- AIO $23.00
- INMD $14.70
- Average True Range (ATR)
- AIO 0.45
- INMD 0.39
- MACD
- AIO 0.07
- INMD 0.09
- Stochastic Oscillator
- AIO 98.67
- INMD 54.66
About AIO Virtus Artificial Intelligence & Technology Opportunities Fund of Beneficial Interest
Virtus Artificial Intelligence & Technology Opportunities Fund is a diversified, limited-term closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income, current gains, and long-term capital appreciation.
About INMD InMode Ltd.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.